PSMA-targeted radioligand therapy with [177Lu]Lu-PSMA-I&T in metastatic castration-resistant prostate cancer: a prospective, multicentre, Swiss registry study

The Lancet Medical Imaging & Theranostics · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles